70% ISOPROPY ALCOHOL SWAB

70% ISOPROPY ALCOHOL SWAB was reported 77 times

70% ISOPROPY ALCOHOL SWAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NAIL CANDIDA 1 0.0417
1 LIGAMENT CALCIFICATION 1 0.0169
2 SWEAT TEST ABNORMAL 1 0.0147
3 UROBILINOGEN URINE INCREASED 1 0.0061
4 ENVIRONMENTAL EXPOSURE 1 0.0042
5 NITRITE URINE PRESENT 1 0.0023
6 SEPSIS SYNDROME 1 0.0020
7 DEVICE MAINTENANCE ISSUE 1 0.0017
8 MEAN PLATELET VOLUME INCREASED 1 0.0017
9 LUNG TRANSPLANT REJECTION 1 0.0015
10 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
11 MYCOBACTERIUM CHELONAE INFECTION 1 0.0014
12 PANCREATIC PSEUDOCYST 1 0.0013
13 NEUROPSYCHIATRIC SYMPTOMS 1 0.0011
14 ANIMAL SCRATCH 1 0.0010
15 EYE COLOUR CHANGE 1 0.0010
16 INFUSION SITE DISCOMFORT 1 0.0010
17 ALLERGY TO ANIMAL 1 0.0009
18 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
19 CHRONIC RESPIRATORY FAILURE 1 0.0008
20 INFUSION SITE IRRITATION 1 0.0008
21 OESOPHAGEAL HAEMORRHAGE 1 0.0008
22 VULVOVAGINAL CANDIDIASIS 1 0.0007
23 CULTURE URINE POSITIVE 1 0.0007
24 INFUSION SITE INDURATION 1 0.0007
25 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
26 BLOOD BICARBONATE DECREASED 1 0.0005
27 HAEMATOCRIT INCREASED 1 0.0004
28 VOLVULUS 1 0.0004
29 ORAL INTAKE REDUCED 1 0.0004
30 EYE OEDEMA 1 0.0004
31 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
32 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
33 PROTEIN TOTAL INCREASED 1 0.0004
34 GAMBLING DISORDER 1 0.0004
35 ORAL FUNGAL INFECTION 1 0.0004
36 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
37 DEVICE POWER SOURCE ISSUE 1 0.0003
38 BLOOD CULTURE POSITIVE 1 0.0003
39 INFUSION SITE PRURITUS 1 0.0003
40 HEPATIC NEOPLASM 1 0.0003
41 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
42 HYPOPNOEA 1 0.0003
43 CAROTID ARTERY STENOSIS 1 0.0003
44 HAEMORRHAGIC DIATHESIS 1 0.0003
45 THROMBOCYTOSIS 1 0.0003
46 POLYDIPSIA 1 0.0003
47 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
48 HOMICIDAL IDEATION 1 0.0002
49 ARTHRITIS BACTERIAL 1 0.0002
50 ONYCHOMYCOSIS 1 0.0002
51 GRIP STRENGTH DECREASED 2 0.0002
52 BLOOD CREATINE INCREASED 1 0.0002
53 HAEMOGLOBIN INCREASED 1 0.0002
54 DIZZINESS POSTURAL 2 0.0002
55 ANEURYSM 1 0.0002
56 PERIORBITAL OEDEMA 1 0.0002
57 OVERWEIGHT 1 0.0002
58 CYSTIC FIBROSIS 1 0.0002
59 MALNUTRITION 2 0.0002
60 PRODUCT LEAKAGE 1 0.0002
61 PERIORBITAL SWELLING 1 0.0002
62 PERONEAL NERVE PALSY 1 0.0002
63 HYPOVOLAEMIA 1 0.0002
64 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
65 SCOLIOSIS 1 0.0002
66 INFUSION SITE EXTRAVASATION 1 0.0002
67 NASAL DRYNESS 1 0.0002
68 INFUSION SITE SWELLING 1 0.0002
69 RESPIRATION ABNORMAL 1 0.0001
70 PAROSMIA 1 0.0001
71 ACIDOSIS 1 0.0001
72 BOWEL MOVEMENT IRREGULARITY 1 0.0001
73 LIPASE INCREASED 1 0.0001
74 RENAL FAILURE CHRONIC 1 0.0001
75 ATRIOVENTRICULAR BLOCK 1 0.0001
76 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
77 HYPOALBUMINAEMIA 1 0.0001
78 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
79 TRICUSPID VALVE INCOMPETENCE 1 0.0001
80 FRUSTRATION TOLERANCE DECREASED 1 0.0001
81 HYPOGLYCAEMIA 6 0.0001
82 POLYURIA 1 0.0001
83 ESCHERICHIA INFECTION 1 0.0001
84 INFUSION SITE ERYTHEMA 1 0.0001
85 CARDIAC MURMUR 1 0.0001
86 COLD SWEAT 2 0.0001
87 PRODUCT COMMUNICATION ISSUE 1 0.0001
88 UROSEPSIS 1 0.0001
89 NERVE COMPRESSION 1 0.0001
90 ATELECTASIS 1 0.0001
91 PHARYNGEAL SWELLING 1 0.0001
92 NEUTROPHIL COUNT INCREASED 1 0.0001
93 RIB FRACTURE 2 0.0001
94 HYPERBILIRUBINAEMIA 1 0.0001
95 PRODUCT ODOUR ABNORMAL 1 0.0001
96 INCONTINENCE 1 0.0001
97 RENAL PAIN 1 0.0001
98 DERMATITIS CONTACT 1 0.0001
99 SCAB 1 0.0001
100 METASTASES TO LUNG 1 0.0001
101 SPINAL PAIN 1 0.0001
102 BURSITIS 1 0.0001
103 GENERALISED OEDEMA 1 0.0001
104 INFUSION SITE PAIN 1 0.0001
105 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
106 ORAL CANDIDIASIS 1 0.0001
107 JOINT RANGE OF MOTION DECREASED 1 0.0001
108 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
109 APPLICATION SITE RASH 1 0.0001
110 HAEMOPTYSIS 2 0.0001
111 CARDIOMYOPATHY 1 0.0001
112 PULMONARY MASS 1 0.0001
113 ECONOMIC PROBLEM 1 0.0001
114 OSTEOPENIA 1 0.0001
115 DEVICE ADHESION ISSUE 1 0.0001
116 MUSCULOSKELETAL CHEST PAIN 1 0.0001
117 DELUSION 1 0.0001
118 LEUKOCYTOSIS 1 0.0001
119 HYPERGLYCAEMIA 2 0.0001
120 FOOT FRACTURE 1 0.0001
121 ORAL HERPES 1 0.0001
122 PRODUCT PHYSICAL ISSUE 1 0.0000
123 INJECTION SITE WARMTH 1 0.0000
124 TOOTH LOSS 1 0.0000
125 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
126 RENAL FAILURE ACUTE 2 0.0000
127 RETCHING 1 0.0000
128 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
129 PANCREATITIS ACUTE 1 0.0000
130 DIABETIC KETOACIDOSIS 1 0.0000
131 INJECTION SITE URTICARIA 1 0.0000
132 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
133 HYPOPHAGIA 1 0.0000
134 DEAFNESS 1 0.0000
135 MUSCULOSKELETAL PAIN 2 0.0000
136 APPLICATION SITE ERYTHEMA 1 0.0000
137 ANHEDONIA 1 0.0000
138 THROAT TIGHTNESS 1 0.0000
139 PALLOR 1 0.0000
140 ANAPHYLACTIC REACTION 2 0.0000
141 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
142 PAIN IN JAW 1 0.0000
143 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
144 HYPERSOMNIA 1 0.0000
145 DYSSTASIA 1 0.0000
146 APHASIA 1 0.0000
147 FEELING HOT 2 0.0000
148 LIMB DISCOMFORT 1 0.0000
149 NERVOUS SYSTEM DISORDER 1 0.0000
150 ANAEMIA 6 0.0000
151 HYPOTHYROIDISM 1 0.0000
152 LACTIC ACIDOSIS 1 0.0000
153 SWELLING FACE 2 0.0000
154 STAPHYLOCOCCAL INFECTION 1 0.0000
155 FUNGAL INFECTION 1 0.0000
156 DEHYDRATION 4 0.0000
157 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
158 HAEMATURIA 1 0.0000
159 RASH MACULAR 1 0.0000
160 LYMPHADENOPATHY 1 0.0000
161 DYSURIA 1 0.0000
162 DYSARTHRIA 1 0.0000
163 DYSPNOEA EXERTIONAL 1 0.0000
164 HALLUCINATION 2 0.0000
165 CHRONIC KIDNEY DISEASE 2 0.0000
166 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
167 HOSPITALISATION 4 0.0000
168 DISORIENTATION 1 0.0000
169 CARDIAC FAILURE CONGESTIVE 2 0.0000
170 RHABDOMYOLYSIS 1 0.0000
171 ROAD TRAFFIC ACCIDENT 1 0.0000
172 OSTEOARTHRITIS 1 0.0000
173 RECTAL HAEMORRHAGE 1 0.0000
174 DEVICE DISLOCATION 1 0.0000
175 SEPTIC SHOCK 1 0.0000
176 TACHYCARDIA 2 0.0000
177 PULMONARY OEDEMA 1 0.0000
178 THROAT IRRITATION 1 0.0000
179 PRODUCT QUALITY ISSUE 3 0.0000
180 SUICIDAL IDEATION 2 0.0000
181 HYPOKALAEMIA 1 0.0000
182 RENAL DISORDER 1 0.0000
183 COGNITIVE DISORDER 1 0.0000
184 FALL 7 0.0000
185 COMA 1 0.0000
186 PRODUCTIVE COUGH 1 0.0000
187 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
188 HYPOTENSION 4 0.0000
189 CELLULITIS 1 0.0000
190 FLUSHING 2 0.0000
191 THERAPY CESSATION 1 0.0000
192 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
193 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
194 OEDEMA 1 0.0000
195 TREMOR 3 0.0000
196 SEPSIS 2 0.0000
197 PANCYTOPENIA 1 0.0000
198 NECK PAIN 1 0.0000
199 LETHARGY 1 0.0000
200 CHILLS 2 0.0000
201 PAIN IN EXTREMITY 5 0.0000
202 IRRITABILITY 1 0.0000
203 JOINT SWELLING 2 0.0000
204 THERAPEUTIC RESPONSE DECREASED 1 0.0000
205 ILL-DEFINED DISORDER 1 0.0000
206 ASTHENIA 6 0.0000
207 GAIT DISTURBANCE 3 0.0000
208 LOSS OF CONSCIOUSNESS 2 0.0000
209 BLOOD CREATININE INCREASED 1 0.0000
210 DEVICE DIFFICULT TO USE 1 0.0000
211 FEBRILE NEUTROPENIA 1 0.0000
212 INJECTION SITE PRURITUS 1 0.0000
213 DEVICE MALFUNCTION 1 0.0000
214 INJURY 1 0.0000
215 SLEEP DISORDER 1 0.0000
216 DYSPNOEA 8 0.0000
217 DIZZINESS 7 0.0000
218 THERAPY INTERRUPTED 1 0.0000
219 RESPIRATORY FAILURE 1 0.0000
220 UNEVALUABLE EVENT 1 0.0000
221 INJECTION SITE SWELLING 1 0.0000
222 PERIPHERAL SWELLING 2 0.0000
223 DRUG DOSE OMISSION BY DEVICE 1 0.0000
224 ARTHRITIS 1 0.0000
225 INJECTION SITE BRUISING 1 0.0000
226 INJECTION SITE HAEMORRHAGE 1 0.0000
227 DRY MOUTH 1 0.0000
228 ABDOMINAL DISCOMFORT 2 0.0000
229 CEREBROVASCULAR ACCIDENT 2 0.0000
230 BALANCE DISORDER 1 0.0000
231 MYOCARDIAL INFARCTION 2 0.0000
232 INTENTIONAL PRODUCT MISUSE 1 0.0000
233 DEVICE ISSUE 1 0.0000
234 ADVERSE EVENT 1 0.0000
235 OROPHARYNGEAL PAIN 1 0.0000
236 WEIGHT DECREASED 3 0.0000
237 DYSPHAGIA 1 0.0000
238 NEUROPATHY PERIPHERAL 1 0.0000
239 HEART RATE INCREASED 1 0.0000
240 SYNCOPE 1 0.0000
241 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
242 CHEST DISCOMFORT 1 0.0000
243 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
244 ERYTHEMA 2 0.0000
245 ILLNESS 1 0.0000
246 PLATELET COUNT DECREASED 1 0.0000
247 THROMBOCYTOPENIA 1 0.0000
248 WEIGHT INCREASED 2 0.0000
249 MUSCULAR WEAKNESS 1 0.0000
250 INCORRECT DOSE ADMINISTERED 2 0.0000
251 DECREASED APPETITE 2 0.0000
252 FEELING ABNORMAL 2 0.0000
253 EMOTIONAL DISTRESS 1 0.0000
254 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
255 VISUAL IMPAIRMENT 1 0.0000
256 INJECTION SITE ERYTHEMA 1 0.0000
257 HYPERHIDROSIS 1 0.0000
258 PSORIASIS 1 0.0000
259 RENAL FAILURE 1 0.0000
260 NEUTROPENIA 1 0.0000
261 VISION BLURRED 1 0.0000
262 ARTHRALGIA 3 0.0000
263 COUGH 2 0.0000
264 INFECTION 1 0.0000
265 RASH 3 0.0000
266 PRODUCT DOSE OMISSION ISSUE 2 0.0000
267 HYPOAESTHESIA 1 0.0000
268 BLOOD PRESSURE INCREASED 1 0.0000
269 ACUTE KIDNEY INJURY 1 0.0000
270 FATIGUE 5 0.0000
271 DIARRHOEA 4 0.0000
272 CONFUSIONAL STATE 1 0.0000
273 DRUG DOSE OMISSION 1 0.0000
274 URINARY TRACT INFECTION 1 0.0000
275 COVID-19 1 0.0000
276 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
277 MUSCLE SPASMS 1 0.0000
278 CHEST PAIN 1 0.0000
279 BLOOD GLUCOSE INCREASED 1 0.0000
280 PRURITUS 2 0.0000
281 SOMNOLENCE 1 0.0000
282 ABDOMINAL PAIN UPPER 1 0.0000
283 DEATH 4 0.0000
284 CONSTIPATION 1 0.0000
285 MALAISE 2 0.0000
286 DEPRESSION 1 0.0000
287 BACK PAIN 1 0.0000
288 ABDOMINAL PAIN 1 0.0000
289 VOMITING 2 0.0000
290 NAUSEA 3 0.0000
291 ANXIETY 1 0.0000
292 INJECTION SITE PAIN 1 0.0000
293 PNEUMONIA 1 0.0000
294 PYREXIA 1 0.0000
295 PAIN 1 0.0000
296 HEADACHE 1 0.0000
297 OFF LABEL USE 1 0.0000
298 DRUG INEFFECTIVE 1 0.0000